Antibody formulation
The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
24.11.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent. |
---|---|
Bibliography: | Application Number: AU20150260758 |